Leishmaniasis Flashcards

1
Q

What is leishmaniasis?

A

A vector-borne parasitic disease caused by protozoa of the genus Leishmania, transmitted by the bite of infected female phlebotomine sandflies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the three main forms of leishmaniasis?

A

Cutaneous leishmaniasis (CL): Skin ulcers at the site of the sandfly bite.

Mucocutaneous leishmaniasis (MCL): Involves destruction of mucous membranes.

Visceral leishmaniasis (VL) (kala-azar): A systemic infection affecting internal organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where is leishmaniasis most prevalent?

A

South Asia (India, Nepal).

East Africa (Sudan, Ethiopia).

Latin America (Brazil, Colombia).

Middle East.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes leishmaniasis?

A

Infection by Leishmania species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the vector for leishmaniasis?

A

Female sandflies of the Phlebotomus or Lutzomyia genera.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does Leishmania infect the host?

A

Sandfly bite introduces promastigotes into the skin.

Promastigotes are phagocytosed by macrophages and transform into amastigotes.

Amastigotes multiply within macrophages, spreading to other tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What factors influence the clinical form of leishmaniasis?

A

Host immune response: Strong Th1 response favors cutaneous disease; Th2 response predisposes to visceral disease.

Leishmania species.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the characteristic lesions of cutaneous leishmaniasis?

A

Painless, erythematous papules or nodules at the bite site.

Progress to ulcers with raised, indurated borders.

Often found on exposed areas (e.g., face, arms, legs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does mucocutaneous leishmaniasis present?

A

Nasal congestion, epistaxis.

Ulceration and destruction of nasal septum, palate, or pharynx.

Disfiguring lesions with risk of airway obstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which species commonly cause MCL?

A

L. braziliensis in Latin America.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the hallmark features of visceral leishmaniasis?

A

Fever, weight loss, and fatigue.

Hepatosplenomegaly.

Pancytopenia (anemia, leukopenia, thrombocytopenia).

Hyperpigmented skin (“kala-azar” or black fever).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What complications are associated with VL?

A

Secondary infections, bleeding disorders, and death if untreated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is leishmaniasis diagnosed?

A

Microscopy: Visualization of amastigotes in tissue smears or biopsies.

Culture: Promastigotes grown in NNN medium.

Molecular tests: PCR for species identification.

Serology: rK39 antigen test for VL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the Montenegro skin test?

A

A delayed hypersensitivity test used in endemic areas to detect prior exposure to Leishmania (positive in CL and MCL).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the first-line treatment for cutaneous leishmaniasis?

A

Topical or intralesional antimonials for localized lesions.

Pentavalent antimonials (e.g., sodium stibogluconate) for widespread or severe cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What alternative therapies are available for CL?

A

Liposomal amphotericin B.

Miltefosine.

Cryotherapy for small lesions.

17
Q

How is mucocutaneous leishmaniasis treated?

A

Pentavalent antimonials as first-line therapy.

Amphotericin B for severe or refractory cases.

18
Q

What is the treatment of choice for visceral leishmaniasis?

A

Liposomal amphotericin B, particularly in immunocompromised patients.

19
Q

What is an alternative treatment for VL in endemic regions?

A

Miltefosine or pentavalent antimonials.

20
Q

How is post-kala-azar dermal leishmaniasis (PKDL) managed?

A

Prolonged courses of antimonials or amphotericin B.